
Certificate pursuant to Regulation 74(5) of SEBI (D&P) Regulations 2018 for the quarter ended on 31-03-2026.
Filed with BSE ·

Certificate pursuant to Regulation 74(5) of SEBI (D&P) Regulations 2018 for the quarter ended on 31-03-2026.
6ix hasn’t read this filing yet.
Jenburkt Pharmaceuticals Ltd on 6ix
Follow Jenburkt Pharmaceuticals into a list and get an email when it puts out news.
Follow Jenburkt Pharmaceuticals